Easy to be bearish while a company is still building. The investor’s job is to look past today’s price and see future potential.
“There is a tide in the affairs of men, which taken at the flood, leads on to fortune.”
$SRXH | $EMJX
Bullish $ASBP: FDA accepted the Pre-IND submission for sublingual aspirin and confirmed written feedback by Jan 2 (in lieu of a meeting). Patented fast-onset delivery platform, microcap valuation, asymmetric upside if regulatory feedback is positive. High risk/high reward.